Absorbable sutures and surgical meshes with prolonged strength retention can allow for wound healing.
Polymers can be used as absorbable implants in the treatment of bone and joint disease.
Tepha’s technology is being used to develop several products for use in cardiac and vascular applications.
FDA Clears First of Its Kind Suture Made Using DNA Technology
U.S. Department of Commerce’s ATP awards Tepha $2 million for development of cardiovascular tissue engineered products.
Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
Tepha’s technology is being used to develop several products for use in cardiac and vascular applications.